Vimarsana
Biggest News Aggregation in the World

Injectable Aesthetics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Injectable Aesthetics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Injectable Aesthetics Today - Breaking & Trending Today

Galderma Launches Restylane VOLYME in China - One of the World's Fastest Growing Aesthetics Markets - Vimarsana News

Galderma Launches Restylane VOLYME in China - One of the World's Fastest Growing Aesthetics Markets

Published: May 23, 2024

Restylane VOLYME is designed for contouring and volumization of the mid-face region to support patients in achieving a youthful, revitalized look The complementary Shape Up Holistic Individualized

Source: finanznachrichten.de
Related Topics:
Emil IvanovJessica CohenChristian MarcouxGalderma RestylaneOptimal Balance TechnologyCorporate CommunicationsShape Up Holistic Individualized TreatmentInjectable AestheticsDermatological SkincareChina Aesthetic Medicine OutlookAccessed MayRestylane InstructionsCommunications OfficerCommunications DirectorInvestor RelationsStrategy DirectorIhr Portfolio
Galderma Launches Restylane VOLYME in China One of the Worlds Fastest Growing Aesthetics Markets - Vimarsana News

Galderma Launches Restylane VOLYME in China One of the Worlds Fastest Growing Aesthetics Markets

Published: May 23, 2024

Galderma SWXGALD announced today the launch of its hyaluronic acid injectable filler Restylane VOLYME in China.

Source: businesswireindia.com
Related Topics:
Christian MarcouxEmil IvanovGalderma RestylaneJessica CohenCorporate CommunicationsOptimal Balance TechnologyShape Up Holistic Individualized TreatmentBalanced ProfileInjectable AestheticsDermatological SkincareChina Aesthetic Medicine OutlookAccessed MayRestylane InstructionsMedia ContactCommunications OfficerCommunications DirectorInvestor RelationsStrategy Director
Galderma Receives Filing Acceptances for Nemolizumab in Prurigo Nodularis and Atopic Dermatitis in Four Additional Countries - Vimarsana News

Galderma Receives Filing Acceptances for Nemolizumab in Prurigo Nodularis and Atopic Dermatitis in Four Additional Countries

Published: May 7, 2024

ZUG, Switzerland--(BUSINESS WIRE)--May 7, 2024--

Source: valdostadailytimes.com
Related Topics:
United KingdomJessica CohenEmil IvanovChristian MarcouxDermatol VenereolAccess ConsortiumChugai Pharmaceutical Co LtdEuropean Medicines AgencyDrug AdministrationEuropean Academy Of DermatologyCorporate CommunicationsBreakthrough TherapyPriority ReviewInjectable AestheticsDermatological SkincareAllergy AsthmaAllergy ClinVenereology EuropeanEur Acad DermatolParticipants With Prurigo NodularisSafety StudyParticipants With PrurigoSubjects With Moderate To Severe AtopicInvestor RelationsBusiness Wire
'Ozempic face' could create a huge market for fillers. One newly-public company wants to cash in. - Vimarsana News

'Ozempic face' could create a huge market for fillers. One newly-public company wants to cash in.

Published: April 25, 2024

Flemming Ornskov, the CEO of Galderma, said that the Ozempic face phenomenon could be a boost for its fillers business.

Source: yahoo.com
Related Topics:
Paul Jarrod FrankFlemming OrnskovSwiss ExchangeInjectable AestheticsBusiness InsiderFacial FillersBusiness InsiderFlemming OrnskovOzempic FaceWeight Loss Drugs
Pharma Giant Plans to Cash in on 'Ozempic Face' Craze With Fillers - Vimarsana News

Pharma Giant Plans to Cash in on 'Ozempic Face' Craze With Fillers

Published: April 25, 2024

Flemming Ornskov, the CEO of Galderma, said that the Ozempic face phenomenon could be a boost for its fillers business.

Source: businessinsider.com
Related Topics:
Flemming OrnskovPaul Jarrod FrankTerms Of ServiceSwiss ExchangeBusiness InsiderInjectable Aesthetics